Focus: Countable Labs develops diagnostic solutions for identifying rare events in PCR workflows, focusing on rare disease detection and precision diagnostics. The company operates in the specialized diagnostics segment with a niche market position.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
A high-risk, early-stage play suitable only for risk-tolerant professionals seeking equity upside and technical ownership in rare disease diagnostics.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Countable Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Countable Labs's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo